Prostate Cancer Clinical Trial

Marker Driven Selection of Patients for Prostate Biopsy and Management

Summary

The purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a panel of blood and urine biomarkers is more effective at detecting prostate cancer than standard of care interpretation of mpMRI with the Prostate Imaging Reporting and Data System (PIRADS).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male participant, aged 40-85 years.
In good general health as evidenced by medical history.
Referred for a biopsy of the prostate for evaluation of prostate cancer due to elevated or increasing prostate-specific antigen (PSA) or an abnormal digital rectal exam (DRE).
Participant must agree to forego testosterone supplementation during the duration of the study due to unknown impacts on prostate cancer biomarkers.

Exclusion Criteria:

Previous or current history of prostate cancer or treatment for prostate cancer.
Previous history of pelvic radiation.
Known allergic reactions to MRI contrast or inability to undergo MRI due to renal toxicity.
Inability to undergo blood draw or biopsy of the prostate as per protocol.
Prior MRI guided biopsy of the prostate for prostate cancer evaluation.
Previous prostate biopsy or prostate procedure within 6 months of enrollment within the trial.
Standard contraindications to MRI, such as allergies to contrast die, renal toxicity, ferromagnetic metal in body/eye, pacemaker, defibrillator, other mechanical device, or extreme claustrophobia (medication with anti-anxiety agents, such as Ativan, may be attempted) will prevent eligibility and will be applied for all protocol-related MRIs.
Patients with impaired decision-making capacity.

Study is for people with:

Prostate Cancer

Estimated Enrollment:

300

Study ID:

NCT04240327

Recruitment Status:

Recruiting

Sponsor:

University of Miami

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Miami
Miami Florida, 33136, United States More Info
Elena M Cortizas, MS
Contact
305-243-6438
[email protected]
Sanoj Punnen, MD, MAS
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

300

Study ID:

NCT04240327

Recruitment Status:

Recruiting

Sponsor:


University of Miami

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.